PEONA, VITTORIA
 Distribuzione geografica
Continente #
NA - Nord America 491
EU - Europa 383
AS - Asia 270
AF - Africa 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.147
Nazione #
US - Stati Uniti d'America 489
CN - Cina 246
IE - Irlanda 122
UA - Ucraina 78
FI - Finlandia 49
DE - Germania 47
SE - Svezia 36
GB - Regno Unito 17
SG - Singapore 16
IT - Italia 14
BE - Belgio 12
FR - Francia 7
IR - Iran 4
CA - Canada 2
EG - Egitto 2
EU - Europa 1
JP - Giappone 1
LV - Lettonia 1
TM - Turkmenistan 1
TR - Turchia 1
TW - Taiwan 1
Totale 1.147
Città #
Dublin 122
Chandler 120
Jacksonville 94
Nanjing 76
Ann Arbor 56
Beijing 45
Boardman 29
Nanchang 28
Ashburn 23
Lawrence 19
Princeton 19
Wilmington 18
Hebei 17
Shenyang 16
Shanghai 15
Helsinki 13
Brussels 12
Jiaxing 11
Tianjin 11
Woodbridge 11
Singapore 10
Hangzhou 9
Medford 7
Verona 6
Changsha 5
Kunming 5
Milan 5
Norwalk 5
Falls Church 4
Piscataway 4
Seattle 4
Jinan 3
Cairo 2
Leawood 2
Nantes 2
Toronto 2
Asaka 1
Ashgabat 1
Auburn Hills 1
Berlin 1
Des Moines 1
Fairfield 1
Framingham 1
Henderson 1
Kashan 1
Lanzhou 1
Los Angeles 1
Nottingham 1
Redwood City 1
Sacramento 1
Shijiazhuang 1
Tainan City 1
Taizhou 1
Tappahannock 1
Washington 1
Wiesbaden 1
Zanjan 1
Totale 851
Nome #
Familial elevation of serum angiotensin converting enzyme activity. 90
Onset of asthma in hairdresser 79
Studies of MR 889, a new synthetic proteinase inhibitor. 73
Nebulized tobramycin in patients with chronic respiratory infections during clinical evolution of Wegener's granulomatosis. 72
Increased serum inflammatory markers as predictors of airway obstruction. 71
Some properties of the alkaline proteinase from Aspergillus melleus. 70
Serum eosinophilic cationic protein: is there a role in respiratory disorders? 65
Diagnosis of enigmatic chronic cough Neurovascular compression in a case of chronic cough progressively leading to compromised quality of life 64
HLA markers in sarcoidosis. 63
Ambroxol and pulmonary toxicity induced by antineoplastic drugs. 62
On the activity of MR 889, a new synthetic proteinase inhibitor. 60
Bioavailability of isoniazid, rifampicin and pyrazinamide (in free combination or fixed-triple formulation) in intermittent antituberculous chemotherapy. 59
Protease-antiprotease imbalance: local evaluation with bronchoalveolar lavage. 57
Mechanisms of lung injury in cystic fibrosis. 56
The cystic fibrosis gene is not likely to be involved in chronic obstructive pulmonary disease. 55
Increased serum inflammatory markers as predictors of airway obstruction. 54
Alpha 1-antitrypsin variants produced by recombinant DNA: differences in elastase inhibitory activity and resistance to oxidant agents. 47
Serum type I and type III procollagen peptide levels in sarcoidosis. 39
Increased serum inflammatory markers as predictors of airway obstruction 18
Totale 1.154
Categoria #
all - tutte 4.512
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.512


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020105 0 0 0 0 0 16 7 16 0 20 46 0
2020/2021176 20 16 6 19 1 21 2 27 6 26 24 8
2021/202287 2 3 2 3 5 2 3 7 4 2 17 37
2022/2023327 29 28 16 27 43 24 0 14 136 3 6 1
2023/202494 11 25 2 7 11 9 2 12 3 2 7 3
2024/202539 3 23 4 9 0 0 0 0 0 0 0 0
Totale 1.154